Clinical Outcomes and Prognosis Markers of Patients With Liver Disease Undergoing Transcatheter Aortic Valve Replacement: A Propensity Score-Matched Analysis [Structural Heart Disease]
Conclusions—
These findings suggested that TAVR is a feasible treatment for severe aortic stenosis in patients with early-stage liver disease or as bridge therapy before a curative treatment of the hepatic condition. Patients with Child-Pugh class B-C, especially in combination with renal impairment, had a very low survival rate, and TAVR should be carefully considered to avoid a futile treatment. These results may contribute to improve the clinical decision-making process and management in patients with liver disease.
Source: Circulation: Cardiovascular Interventions - Category: Cardiology Authors: Tirado-Conte, G., Rodes-Cabau, J., Rodriguez-Olivares, R., Barbanti, M., Lhermusier, T., Amat-Santos, I., Toggweiler, S., Cheema, A. N., Munoz-Garcia, A. J., Serra, V., Giordana, F., Veiga, G., Jimenez-Quevedo, P., Campelo-Parada, F., Loretz, L., Todaro, Tags: Valvular Heart Disease, Aortic Valve Replacement/Transcatheter Aortic Valve Implantation, Mortality/Survival, Quality and Outcomes Structural Heart Disease Source Type: research
More News: Aortic Stenosis | Bleeding | Cardiology | Cardiovascular | Cardiovascular & Thoracic Surgery | Children | Heart | Heart Disease | Heart Valve Surgery | Liver | Liver Disease | Study | Urology & Nephrology